Zidovudine therapy in HIV infection: which patients should be treated and when.
Barry
M G
MG
Department of Pharmacology and Therapeutics, University of Liverpool, UK.
Back
D J
DJ
Breckenridge
A M
AM
D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000145:classification / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D010766:Phosphorylation; D011247:Pregnancy; D016032:Randomized Controlled Trials as Topic; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D014944:World Health Organization; D015215:Zidovudine / Q000494:pharmacology / Q000627:therapeutic use*
D000998:Antiviral Agents; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine